Senior Integration Developer

⚙️ Industry: Pharmaceutical. Remote work: 100% remotely. Project language: English. Project length: Long-term cooperation. ⏰ Start: ASAP. Rate: up to 42 EUR/h on B2B. Emagine is seeking a highly skilled Senior Integration Developer to join our client’s project. The ideal candidate will have a strong background in event-driven design and experience in developing solutions for GxP-compliant pharma systems . You will be instrumental in building scalable cloud solutions that enhance software product releases and improve patient outcomes. A focus on quality, data integrity, and collaboration with cross-functional teams is essential for success in this role. Main Responsibilities: As a Senior Integration Developer, your primary responsibility will be to design and build effective integration solutions. Additional responsibilities will include: Developing and implementing solutions using event-driven architecture for pharma systems. Ensuring compliance with regulatory requirements and industry standards. Creating reusable templates for best practices. Optimizing system performance and scalability. Implementing CI/CD best practices and automated testing. Collaborating with cross-functional teams to maintain integrations, data flows, events, and APIs. Conducting regular reviews to ensure data integrity. Facilitating effective communication among stakeholders. Key Requirements: Degree in Computer Science, Software Development, or Engineering. Experience with Event-Driven Design, Kafka, and Integrations. Proficiency in designing and developing Kafka architectures using Flink or similar technologies. Familiarity with automated testing frameworks. Experience with CI/CD pipelines using Azure DevOps or similar. Proficiency in Python or Java programming languages. Experience in the pharmaceutical industry or regulated sectors is advantageous. Nice to Have: Additional complementary skills include experience with cloud architectures and knowledge of data integrity best practices.

Location: Poznań, PL

Posted Date: 4/25/2025